| Field | Specification |
|---|---|
| UniProt # | |
| Applications | |
| Sensitivity | |
| Detection range | |
| Detection method | |
| Assay time | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Scientific Background
This ELISA kit applies to the in vitro quantitative determination of Human LDHA concentrations in serum, plasma and other biological fluids.
Assay Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human LDHA. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human LDHA and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human LDHA, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human LDHA. You can calculate the concentration of Human LDHA in the samples by comparing the OD of the samples to the standard curve.
Performance Specifications
| Sensitivity | 0.47 ng/mL |
|---|---|
| Detection Range | 0.78-50 ng/mL |
| Total Assay Time | 3 h 30 min |
| Compatible Sample Types | Serum, plasma and other biological fluids |
| Species Reactivity | Human |
| Detection Method | Sandwich |
| Precision (CV) | Both intra-CV and inter-CV are < 10%. |
| Recovery Rate | 80%-120% |
| Storage | 2-8℃,12 months |
✓ Research-Grade Validation
Specificity
This kit recognizes Human LDHA in samples. No significant cross-reactivity or interference between Human LDHA and analogues was observed
Safety & Regulatory
Handle reagents in accordance with institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for complete hazard and handling information. Contains components that may require special disposal procedures per local regulations.
This kit is validated for use with Serum, plasma and other biological fluids. For unlisted matrices (e.g., tissue lysate, urine), perform a spike-and-recovery experiment to confirm assay performance before generating reportable data. Sample dilution in the kit's provided diluent is recommended to minimize matrix interference.
The minimum detectable concentration (sensitivity) of this kit is 0.47 ng/mL. Values below this threshold should be reported as below the limit of detection (<LOD) and should not be extrapolated from the standard curve.
The total assay time from sample addition to absorbance reading is approximately 3 h 30 min, including all incubation, wash, and substrate steps. Hands-on time is typically 1–2 hours; most steps involve passive plate incubation. Plan the assay as a single uninterrupted session for best results.
Standard components of this Sandwich ELISA Kit typically include: pre-coated microplate (96-well strip format), lyophilized or liquid recombinant LDHA standard, detection antibody, streptavidin-HRP conjugate, TMB substrate, stop solution, wash buffer concentrate, and sample/standard diluent. Refer to the kit insert or datasheet for the exact component list and storage requirements.
This kit uses colorimetric (TMB/HRP) detection and requires a standard microplate absorbance reader capable of measuring at 450 nm. A reference wavelength of 570 nm or 630 nm is recommended to reduce background. No specialized fluorescence or luminescence reader is needed. Ensure the instrument is calibrated and the plate is clean and free of condensation before reading.
The Liver function-related indicators we have ELISA kits are here for your reference: E-EL-H0556 Human LDHA(Lactate Dehydrogenase A) ELISA Kit E-EL-H2598 Human ALPL(Alkaline Phosphatase, Liver/Bone/Kidney) ELISA Kit E-EL-H6105 Human ALB(Albumin) ELISA Kit E-EL-0076 Bb(Bilirubin) ELISA Kit
Tissue samples may contain endogenous or exogenous proteases during processing, leading to degradation of extracted proteins. Therefore, it's necessary to add protease inhibitors during processing to ensure the integrity of target proteins. If customers can keep samples cold and handle them quickly during processing, omitting the protease inhibitor may not have a significant effect. After preparation, samples should be tested promptly or immediately aliquoted and frozen at -20°C or -80°C.
What is the range of enzyme activity of your IL-2 freeze-dried powder
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
YBX1-LDHB axis orchestrates pyruvate production from lactate to promote ICC initiation and development (2026) PHARMACOLOGICAL RESEARCH. 10.1016/j.phrs.2026.108110
A Proposed Association between Improving Energy Metabolism of HepG2 Cells by Plant Extracts and Increasing Their Sensitivity to Doxorubicin (2023) Toxics. 10.3390/toxics11020182
Evaluation of mutagenic, cytotoxic, mitochondrial dysfunction, apoptotic activity, and acute toxicity of ethanolic extract of Cissus quadrangularis (2022) TOXICOLOGY. 10.1016/j.tox.2022.153373
Stress granules inhibit endoplasmic reticulum stress-mediated apoptosis during hypoxia-induced injury in acute liver failure (2023) WORLD JOURNAL OF GASTROENTEROLOGY. 10.3748/wjg.v29.i8.1315
Inhibition of glycolysis by targeting lactate dehydrogenase A facilitates hyaluronan synthase 2 synthesis in synovial fibroblasts of temporomandibular joint osteoarthritis (2020) BONE. 10.1016/j.bone.2020.115584
The effect of coenzyme Q10 plus trimetazidine on acute viral myocarditis treatment (2021) American Journal of Translational Research. PMID:35035725
Combination of oncolytic adenovirus ZD55 harboring TRAIL-IETD-MnSOD and cytokine-induced killer cells against lung cancer (2021) Annals of Translational Medicine. 10.21037/atm-21-4479
Thermally Triggered Release and Nonthermal Antitumor Effects of Magnetic Thermosensitive Lipid–Polymer Hybrid Nanoparticles in Hep G2 Cells Under Alternating Magnetic Field (2026) Nano Select. 10.1002/nano.70119
MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway (2021) Bioengineered. 10.1080/21655979.2021.2006974
NCAPD3 is involved in papillary thyroid carcinoma proliferation, metastasis, and aerobic glycolytic pathway (2025) Discover Oncology. 10.1007/s12672-025-02767-x
Fusobacterium nucleatum Enhances Immune Escape in Colorectal Cancer by Inducing H3K18 Lactylation of CD274 (PD-L1) Protein Through Lactate Accumulation (2026) APMIS. 10.1111/apm.70134
Downregulation of P300/CBP-Associated Factor Attenuates Myocardial Ischemia-Reperfusion Injury Via Inhibiting Autophagy (2020) International Journal of Medical Sciences. 10.7150/ijms.44604
Investigation of glucose catabolism in hypoxic Mcf 7 breast cancer culture (2021) CYTOTECHNOLOGY. 10.1007/s10616-021-00459-2
Evaluation of Serum Pyruvate Kinase M2 and Key Glycolytic Signatures and Its Correlation with Phosphatidylinositol-3-kinase/Akt/Mammalian Target of Rapamycin Pathway in Women with Breast Carcinoma (2024) Biomedical and Biotechnology Research Journal. 10.4103/bbrj.bbrj_136_24
